![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjkRMSe2FkiMDaAkFcK4d-YwegLGlMXGihR8xGRF9RstySYzVRAaEtemuG5z070Bn9WBP38ylNgjDelCf_4Pot1bET4p7EgMhf-ZS-H_MbgP0HUNB8M8DXbUoKK3kkCYhYc7QYCS0g4kEo/s400/15th+International+Conference+on+Human+Retrovirology%252C+Belgium+5-8+June.jpg)
About the conference
The aim of this biennial meeting is to promote discussion and share new findings between researchers and clinicians for the benefit of patients infected by human T-lymphotropic virus (HTLV). HTLV infects approximately 15-20 million individuals worldwide and causes a broad spectrum of diseases including neurodegeneration and leukemia. Due to the recent exciting discoveries in this field, a particular session will focus on endogenous retroviruses, foamy viruses and XMRV.
Read more>>
1 comment:
But De Meirleir must present his findings on XMRV a day after the conference on june 9th!
Post a Comment